Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI).
Orphazyme A/S (CPSE:ORPHA) completed the acquisition of an additional unknown minority stake in CombiGene AB (publ) (OM:COMBI) on February 21, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.77 SEK | +0.27% | -2.08% | +40.15% |
Mar. 13 | CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries | CI |
Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,090 DKK | -0.91% | +4.11% | 5.51M | ||
3.77 SEK | +0.27% | -2.08% | 6.81M | ||
1st Jan change | Capi. | |
---|---|---|
+40.15% | 6.81M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |